Omnic Ocas (Tamsulosin Hydrochloride)

Tamsulosin hydrochloride, the active ingredient in Omnic Ocas, is an Alpha‑1‑adrenergic receptor blocker presented as a 0.4 mg tablet for oral use. It treats lower urinary tract symptoms associated with benign prostatic hyperplasia in adult males. GNH USA supplies Omnic Ocas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omnic Ocas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omnic Ocas, a selective alpha‑1 blocker, is used to improve urinary flow in conditions affecting the lower urinary tract.

- Benign prostatic hyperplasia (BPH): relieves urinary obstruction and reduces frequency, urgency and nocturia. - Chronic prostatitis: may improve urinary symptoms associated with chronic inflammation of the prostate. - Post‑void residual reduction: helps decrease residual urine volume after voiding in men with bladder outlet obstruction.

Tamsulosin is generally well‑tolerated, but patients may experience adverse reactions.

Common Side Effects: - Dizziness - Headache - Abnormal ejaculation - Nasal congestion - Orthostatic hypotension - Fatigue

Serious or Rare Side Effects: - Priapism - Severe hypotension - Allergic skin reactions (rash, hives) - Angio‑Angloma ang   

When ");